Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
PFIZER LIMITED ( (IN:PFIZER) ) has provided an announcement.
Pfizer Limited has disclosed that it received an order from the Additional Commissioner of GST & CX, Kolkata, following a GST audit for West Bengal covering financial years 2018-19 to 2022-23, raising a tax demand of Rs 4.40 crore and an equivalent penalty, totalling about Rs 8.79 crore plus interest, over alleged incorrect availment of input tax credit. The company maintains that the demand is not maintainable, plans to appeal the order, and has stated that the proceedings are not expected to have any material impact on its financials, operations or business activities, suggesting limited near-term implications for shareholders and other stakeholders.
More about PFIZER LIMITED
Pfizer Limited is an Indian pharmaceutical company engaged in the manufacture and marketing of branded prescription medicines and healthcare products, operating in the regulated healthcare and life sciences sector with a focus on the domestic market and regulated exports.
Average Trading Volume: 4,868
Technical Sentiment Signal: Buy
Current Market Cap: 231B INR
Find detailed analytics on PFIZER stock on TipRanks’ Stock Analysis page.